Latif Nasser

For like one pill that I take- One a day.

Which, as you can imagine, it angered a lot of people with Hep C. In total, it costs $84,000.

And if you think about the fact that in 2014, we know at least 70,000 people got this drug.

Wait, I just want to say that I just timesed out 70,000 times 84,000, and I got something with seven zeros in it.

It's 588, and then there's seven zeros, which is like $5 billion?

Yes.

The big question is how states will pay for what could be upwards of... And so we have a situation where states are basically having to ration.

Yeah.

Similar restrictions are happening in other states.

Florida, it's happening in Oregon, Illinois.

And then there's Arizona.

Out of the entire state, public insurance only approves 180 people for treatment.

What, just 180?

Just 180.

Now, when I talk to a representative of the company that makes the drug... Greg Alton, Executive Vice President for Corporate and Medical Affairs for Gillette Sciences.

He says, you got to keep in mind, this is not a chronic care situation.

This is a...

cure.

Here, you're actually curing a person of a disease.

We're talking about 12 weeks of therapy, period.